ASO Author Reflections: Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer: Is Combined Radiotherapy Necessary?
Crossref DOI link: https://doi.org/10.1245/s10434-019-07245-7
Published Online: 2019-02-19
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nagakawa, Yuichi http://orcid.org/0000-0003-1169-8160
Text and Data Mining valid from 2019-02-19
Article History
Received: 5 February 2019
First Online: 19 February 2019
Disclosures
: Yuichi Nagakawa has no conflicts of interest to disclose.